Scheffer, Ingrid E.
Royal Children's Hospital · The University of Melbourne · Murdoch Children's Research Institute · Austin Health
93 papers on CoChatORCID 0000-0002-2311-2174
Most cited papers
- Verified
Lamotrigine can be beneficial in patients with Dravet syndrome
Dalic, L., Mullen, S. A., Roulet Perez, E., & Scheffer, I. (2015) · Developmental Medicine & Child Neurology
Epilepsy research and treatmentPharmacological Effects and Toxicity Studies
Cited by 64
- Verified
Widespread genomic influences on phenotype in Dravet syndrome, a ‘monogenic’ condition
Martins Custodio, H., Clayton, L. M., Bellampalli, R., Pagni, S., Silvennoinen, K., Caswell, R., Genomics England Research Consortium, Ambrose, J. C., Arumugam, P., Bevers, R., et al. (2023) · Brain
Epilepsy research and treatmentGenomics and Rare Diseases
Cited by 62
- Verified
NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns
Stamberger, H., Hammer, T. B., Gardella, E., Vlaskamp, D. R. M., Bertelsen, B., Mandelstam, S., de Lange, I., Zhang, J., Myers, C. T., Fenger, C., et al. (2021) · Genetics in Medicine
Genetics and Neurodevelopmental DisordersEpilepsy research and treatment
Cited by 57
- Verified
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study
Knupp, K. G., Scheffer, I. E., Ceulemans, B., Sullivan, J., Nickels, K. C., Lagae, L., Guerrini, R., Zuberi, S. M., Nabbout, R., Riney, K., et al. (2023) · Epilepsia
Epilepsy research and treatmentPharmacological Effects and Toxicity Studies
Cited by 55
- Verified
Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies
Palmer, E. E., Howell, K., & Scheffer, I. E. (2021) · Neurotherapeutics
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 53
- Verified
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment
Bishop, K. I., Isquith, P. K., Gioia, G. A., Knupp, K. G., Scheffer, I. E., Nabbout, R., Specchio, N., Sullivan, J., Auvin, S., Helen Cross, J., et al. (2023) · Epilepsy & Behavior
Epilepsy research and treatmentPharmacological Effects and Toxicity Studies
Cited by 43
- Verified
The role of common genetic variation in presumed monogenic epilepsies
Campbell, C., Leu, C., Feng, Y.-C. A., Wolking, S., Moreau, C., Ellis, C., Ganesan, S., Martins, H., Oliver, K., Boothman, I., et al. (2022) · eBioMedicine
Epilepsy research and treatmentGenomics and Rare Diseases
Cited by 42
- Verified
Schizophrenia is a later‐onset feature ofPCDH 19 Girls Clustering Epilepsy
Vlaskamp, D. R. M., Bassett, A. S., Sullivan, J. E., Robblee, J., Sadleir, L. G., Scheffer, I. E., & Andrade, D. M. (2019) · Epilepsia
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 39
- Verified
Exome Sequencing and the Identification of New Genes and Shared Mechanisms in Polymicrogyria
Akula, S. K., Chen, A. Y., Neil, J. E., Shao, D. D., Mo, A., Hylton, N. K., DiTroia, S., Ganesh, V. S., Smith, R. S., O’Kane, K., et al. (2023) · JAMA Neurology
Fetal and Pediatric Neurological DisordersGenomics and Rare Diseases
Cited by 37
- Verified
Somatic Mosaic Pathogenic Variant Gradient Detected in Trace Brain Tissue From Stereo-EEG Depth Electrodes
Ye, Z., Bennett, M. F., Neal, A., Laing, J. A., Hunn, M. K., Wittayacharoenpong, T., Todaro, M., Patel, S. K., Bahlo, M., Kwan, P., et al. (2022) · Neurology
Epilepsy research and treatmentGenomics and Rare Diseases
Cited by 35
- Verified
Fatal Cerebral Edema With Status Epilepticus in Children With Dravet Syndrome: Report of 5 Cases
Myers, K. A., McMahon, J. M., Mandelstam, S. A., Mackay, M. T., Kalnins, R. M., Leventer, R. J., & Scheffer, I. E. (2017) · Pediatrics
Epilepsy research and treatmentInfectious Encephalopathies and Encephalitis
Cited by 34
- Verified
Dysarthria and broader motor speech deficits in Dravet syndrome
Turner, S. J., Brown, A., Arpone, M., Anderson, V., Morgan, A. T., & Scheffer, I. E. (2017) · Neurology
Epilepsy research and treatmentLanguage Development and Disorders
Cited by 33
- Verified
Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies
van der Veen, S., Tse, G. T. W., Ferretti, A., Garone, G., Post, B., Specchio, N., Fung, V. S. C., Trivisano, M., & Scheffer, I. E. (2023) · Neurology
Epilepsy research and treatmentDeep Brain Stimulation and Movement Disorders
Cited by 32
- Verified
Diagnostic utility of DNA methylation analysis in genetically unsolved pediatric epilepsies and CHD2 episignature refinement
LaFlamme, C. W., Rastin, C., Sengupta, S., Pennington, H. E., Russ-Hall, S. J., Schneider, A. L., Bonkowski, E. S., Almanza Fuerte, E. P., Allan, T. J., Zalusky, M. P.-G., et al. (2024) · Nature Communications
Epilepsy research and treatmentEpigenetics and DNA Methylation
Cited by 31
- Verified
Head stereotypies in STXBP 1 encephalopathy
Kim, Y. O., Korff, C. M., Villaluz, M. M. G., Suls, A., Weckhuysen, S., De Jonghe, P., & Scheffer, I. E. (2013) · Developmental Medicine & Child Neurology
Genetics and Neurodevelopmental DisordersEpilepsy research and treatment
Cited by 25
- Verified
Solving the Etiology of Developmental and Epileptic Encephalopathy with Spike–Wave Activation in Sleep (D/EE‐SWAS )
Viswanathan, S., Oliver, K. L., Regan, B. M., Schneider, A. L., Myers, C. T., Mehaffey, M. G., LaCroix, A. J., Antony, J., Webster, R., Cardamone, M., et al. (2024) · Annals of Neurology
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 23
- Verified
WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk
Oliver, K. L., Trivisano, M., Mandelstam, S. A., De Dominicis, A., Francis, D. I., Green, T. E., Muir, A. M., Chowdhary, A., Hertzberg, C., Goldhahn, K., et al. (2023) · Epilepsia
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 23
- Verified
Does long‐term phenytoin have a place in Dravet syndrome?
Zographos, G. A., Russ‐Hall, S. J., & Scheffer, I. E. (2022) · Annals of Clinical and Translational Neurology
Epilepsy research and treatmentPharmacological Effects and Toxicity Studies
Cited by 17
- Verified
Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability
Francis, D. I., Stark, Z., Scheffer, I. E., Tan, T. Y., Murali, K., Gallacher, L., Amor, D. J., Goel, H., Downie, L., Stutterd, C. A., et al. (2023) · European Journal of Human Genetics
Genomic variations and chromosomal abnormalitiesGenomics and Rare Diseases
Cited by 16
- Verified
De novo missense variants in the E3 ubiquitin ligase adaptor KLHL20 cause a developmental disorder with intellectual disability, epilepsy, and autism spectrum disorder
Sleyp, Y., Valenzuela, I., Accogli, A., Ballon, K., Ben-Zeev, B., Berkovic, S. F., Broly, M., Callaerts, P., Caylor, R. C., Charles, P., et al. (2022) · Genetics in Medicine
Genetics and Neurodevelopmental DisordersGenomics and Rare Diseases
Cited by 10
- Verified
Why should a neurologist worry about climate change?
Sisodiya, S. M., Scheffer, I. E., Lowenstein, D. H., & Free, S. L. (2019) · The Lancet Neurology
Climate Change and Health ImpactsClimate Change and Environmental Impact
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free